What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Disease
The scientist’s investigation covers issues in Pulmonary hypertension, Internal medicine, Cardiology, Surgery and Anesthesia.
His biological study spans a wide range of topics, including Lung transplantation, Respiratory disease, Intensive care medicine, Bosentan and Hemodynamics.
His Internal medicine study focuses mostly on Vascular resistance, Pulmonary embolism, Riociguat, Prospective cohort study and Brain natriuretic peptide.
His study looks at the relationship between Cardiology and topics such as Endothelin receptor antagonist, which overlap with VO2 max and Cirrhosis.
The concepts of his Surgery study are interwoven with issues in Gastroenterology, Placebo, Odds ratio and Lung.
His Anesthesia study integrates concerns from other disciplines, such as Transplantation and Iloprost.
His most cited work include:
- 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). (3529 citations)
- Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT) (3230 citations)
- Inhaled iloprost for severe pulmonary hypertension. (1413 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Internal medicine, Pulmonary hypertension, Cardiology, Surgery and In patient.
His study on Internal medicine is mostly dedicated to connecting different topics, such as Placebo.
His Pulmonary hypertension research incorporates themes from Respiratory disease, Anesthesia, Iloprost, Intensive care medicine and Pulmonary artery.
His Cardiology study combines topics in areas such as Bosentan and Endothelin receptor antagonist.
His Surgery research is multidisciplinary, incorporating perspectives in Gastroenterology, Lung and Combination therapy.
The Riociguat study combines topics in areas such as Respite care and Tolerability.
He most often published in these fields:
- Internal medicine (55.70%)
- Pulmonary hypertension (40.00%)
- Cardiology (35.37%)
What were the highlights of his more recent work (between 2019-2021)?
- Internal medicine (55.70%)
- Cardiology (35.37%)
- Pulmonary hypertension (40.00%)
In recent papers he was focusing on the following fields of study:
His main research concerns Internal medicine, Cardiology, Pulmonary hypertension, In patient and Riociguat.
Marius M. Hoeper focuses mostly in the field of Internal medicine, narrowing it down to matters related to Gastroenterology and, in some cases, Liver transplantation and Cohort.
A large part of his Cardiology studies is devoted to Perfusion.
Marius M. Hoeper has included themes like Targeted therapy, Intensive care medicine, Pulmonary artery and DLCO in his Pulmonary hypertension study.
His Intensive care medicine research includes elements of Pulmonary embolism and MEDLINE.
As a part of the same scientific family, Marius M. Hoeper mostly works in the field of Riociguat, focusing on Post-hoc analysis and, on occasion, Vascular resistance.
Between 2019 and 2021, his most popular works were:
- Reappearance of effector T cells is associated with recovery from COVID-19. (33 citations)
- Injury to the Endothelial Glycocalyx in Critically Ill Patients with COVID-19. (15 citations)
- Low serum neutralizing anti-SARS-CoV-2 S antibody levels in mildly affected COVID-19 convalescent patients revealed by two different detection methods. (14 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Disease
Internal medicine, Severe acute respiratory syndrome coronavirus 2, Cardiology, Antibody and Immunology are his primary areas of study.
Internal medicine is represented through his Pulmonary hypertension, Randomized controlled trial, Heart failure, Area under the curve and Disease research.
Marius M. Hoeper works in the field of Pulmonary hypertension, focusing on Idiopathic Pulmonary Arterial Hypertension in particular.
His Randomized controlled trial study combines topics from a wide range of disciplines, such as Odds ratio, Framingham Risk Score, Placebo, Selexipag and Disease management.
His biological study spans a wide range of topics, including Biomarker, Hemodynamics, ARDS and Inflammation.
His research is interdisciplinary, bridging the disciplines of Epidemiology and Cardiology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
